Seizure Disorders

Latest News

No Evidence of Increased Suicidality With Common Antiseizure Drug Use

This meta-analysis aimed to evaluate whether there’s evidence that supports the FDA-mandated warning for increased suicidality risk with antiseizure drug usage among people with epilepsy.

Late-Onset Epilepsy Linked to Increased Risk for Death in Older Adults

Researchers explored the risk for death in late-onset epilepsy by analyzing data from the prospective Atherosclerosis Risk in Communities (ARIC) study.

Briviact Approval Expanded to Include Younger Patients with Partial-Onset Seizures

Briviact is now indicated for the treatment of partial-onset seizures in patients 1 month of age and older.

Eslicarbazepine Acetate Reduced Seizures in Adults With Treatment-Resistant Focal Epilepsy

Primary outcomes were a 50% or greater reduction in seizure frequency and the proportion of patients with complete cessation of seizures by trial conclusion.

Cannabis-Based Drug for Pediatric Epilepsy

Neurology advisor spoke with Charuta Joshi, MBBS regarding the use of the cannabis-based Epidiolex in the treatment of pediatric seizures.

Evidence to Support Suicidality Warning for Newer Antiseizure Meds Lacking

The analysis included 5 antiseizure medications (eslicarbazepine, perampanel, brivaracetam, cannabidiol, and cenobamate) evaluated in 17 randomized clinical trials.

The Role of the Gut-Brain Axis and S-equol in Epilepsy Treatment

A team of researchers sought to determine role of the gut-brain axis as a possible therapeutic target for Theiler murine encephalomyelitis (TMEV) linked seizures.

Molecular Diagnostics Reveal Novel Causal Lesions in Drug-Resistant Focal Epilepsy

Study researchers sought to assess how the diagnosis and understanding of focal epilepsy has improved with the inclusion of molecular genetic data in clinical decision making.

Targeted Therapy for Recurrent Seizure-Related GRIN1 Variant

This case study detailed a pediatric patient with drug-resistant seizures and early-onset epileptic encephalopathy who carried a GRIN1 variant.

Musicogenic Epilepsy and Antiglutamic Decarboxylase Antibodies: A Case Report

In this case report, a team of investigators highlighted findings in a 50-year-old woman who has been diagnosed with a seizure disorder for 14 years.